TAAR1 Modulates Cortical Glutamate NMDA Receptor Function-Reference-Cited by-同舟云学术

TAAR1 Modulates Cortical Glutamate NMDA Receptor Function

Published:2015-03-09 Issue:9 Volume:40 Page:2217-2227
ISSN:0893-133X
Container-title:Neuropsychopharmacology
language:en
Short-container-title:Neuropsychopharmacol

Author:

Espinoza Stefano,Lignani Gabriele,Caffino Lucia,Maggi Silvia,Sukhanov Ilya,Leo Damiana,Mus Liudmila,Emanuele Marco,Ronzitti Giuseppe,Harmeier Anja,Medrihan Lucian,Sotnikova Tatyana D,Chieregatti Evelina,Hoener Marius C,Benfenati Fabio,Tucci Valter,Fumagalli Fabio,Gainetdinov Raul R

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Pharmacology

Link

http://www.nature.com/articles/npp201565.pdf

Reference40 articles.

1. Achat-Mendes C, Lynch LJ, Sullivan KA, Vallender EJ, Miller GM (2012). Augmentation of methamphetamine-induced behaviors in transgenic mice lacking the trace amine-associated receptor 1. Pharmacol Biochem Behav 101: 201–207.

2. Bari A, Robbins TW (2013). Inhibition and impulsivity: behavioral and neural basis of response control. Prog Neurobiol 108: 44–79.

3. Berger DF, Sagvolden T (1998). Sex differences in operant discrimination behaviour in an animal model of attention-deficit hyperactivity disorder. Behav Brain Res 94: 73–82.

4. Borowsky B, Adham N, Jones KA, Raddatz R, Artymyshyn R, Ogozalek KL et al (2001). Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc Natl Acad Sci U S A 98: 8966–8971.

5. Bunzow JR, Sonders MS, Arttamangkul S, Harrison LM, Zhang G, Quigley DI et al (2001). Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol Pharmacol 60: 1181–1188.

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TAAR1 and 5-HT1B receptor agonists attenuate autism-like irritability and aggression in rats prenatally exposed to valproic acid;Pharmacology Biochemistry and Behavior;2024-12

2. Computational Methods for the Discovery and Optimization of TAAR1 and TAAR5 Ligands;International Journal of Molecular Sciences;2024-07-27

3. Assessment of Innovative Pharmacological Targets in Schizophrenia;Current Treatment Options in Psychiatry;2024-07-13

4. SEP‐363856 exerts neuroprotection through the PI3K/AKT/GSK‐3β signaling pathway in a dual‐hit neurodevelopmental model of schizophrenia‐like mice;Drug Development Research;2024-06

5. Beyond dopamine: Novel strategies for schizophrenia treatment;Medicinal Research Reviews;2024-04-23